FDA — authorised 25 April 1939
- Marketing authorisation holder: LILLY
- Status: approved
FDA authorised Eramin on 25 April 1939
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 25 April 1939.
LILLY holds the US marketing authorisation.